502 related articles for article (PubMed ID: 33403043)
1. Deltex3 inhibits Epithelial Mesenchymal Transition in Papillary Thyroid Carcinoma via promoting ubiquitination of XRCC5 to regulate the AKT signal pathway.
Wang L; Huang Y; Liu C; Guo M; Ma Z; He J; Wang A; Sun X; Liu Z
J Cancer; 2021; 12(3):860-873. PubMed ID: 33403043
[No Abstract] [Full Text] [Related]
2. MicroRNA-486 inhibits cell proliferation, invasion and migration via down-regulating the TENM1 expressions and affecting ERK and Akt signaling pathways and epithelial-to-mesenchymal transition in papillary thyroid carcinoma.
Sun YH; Liu ZF; Yang BB; Yu B
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8429-8439. PubMed ID: 31646573
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-31 inhibits papillary thyroid carcinoma cell biological progression by directly targeting SOX11 and regulating epithelial-to-mesenchymal transition, ERK and Akt signaling pathways.
Wang Y; Liu BG; Zhou CX
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5863-5873. PubMed ID: 31298337
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-26a suppresses the malignant biological behaviors of papillary thyroid carcinoma by targeting ROCK1 and regulating PI3K/AKT signaling pathway.
Wu YC; Li SY; Jia YF
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8940-8949. PubMed ID: 31696481
[TBL] [Abstract][Full Text] [Related]
5. TFF3 Contributes to Epithelial-Mesenchymal Transition (EMT) in Papillary Thyroid Carcinoma Cells via the MAPK/ERK Signaling Pathway.
Lin X; Zhang H; Dai J; Zhang W; Zhang J; Xue G; Wu J
J Cancer; 2018; 9(23):4430-4439. PubMed ID: 30519349
[No Abstract] [Full Text] [Related]
6. Knockdown of
Chen D; Huang Z; Ning Y; Lou C
Cancer Manag Res; 2020; 12():8757-8771. PubMed ID: 33061573
[TBL] [Abstract][Full Text] [Related]
7.
Liang WQ; Zeng D; Chen CF; Sun SM; Lu XF; Peng CY; Lin HY
Cancer Manag Res; 2019; 11():2059-2072. PubMed ID: 30881130
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-1271 inhibits the progression of papillary thyroid carcinoma by targeting IRS1 and inactivating AKT pathway.
Chen Y; Hao SA; Jiang Y; Gao B; Tian WG; Zhang S; Guo LJ; Wang LL; Luo DL
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7989-7999. PubMed ID: 31599424
[TBL] [Abstract][Full Text] [Related]
9. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
[TBL] [Abstract][Full Text] [Related]
10. LncRNA CASC2 expression is down- regulated in papillary thyroid cancer and promotes cell invasion by affecting EMT pathway.
Zhou T; Zhong M; Zhang S; Wang Z; Xie R; Xiong C; Lv Y; Chen W; Yu J
Cancer Biomark; 2018; 23(2):185-191. PubMed ID: 30175973
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitination of NOTCH2 by DTX3 suppresses the proliferation and migration of human esophageal carcinoma.
Ding XY; Hu HY; Huang KN; Wei RQ; Min J; Qi C; Tang H; Qin X
Cancer Sci; 2020 Feb; 111(2):489-501. PubMed ID: 31854042
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between activated STAT3 protein and epithelial-mesenchymal transition in papillary thyroid carcinoma].
Zhang Z; Bai Y; Li P; Zhao J; Wang Y; Sun L; Tang J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 27(22):1265-8. PubMed ID: 24616987
[TBL] [Abstract][Full Text] [Related]
13. NECTIN4 promotes papillary thyroid cancer cell proliferation, migration, and invasion and triggers EMT by activating AKT.
Hao RT; Zheng C; Wu CY; Xia EJ; Zhou XF; Quan RD; Zhang XH
Cancer Manag Res; 2019; 11():2565-2578. PubMed ID: 31114323
[TBL] [Abstract][Full Text] [Related]
14. LncRNA LINC00673 inhibits p53 expression by interacting with EZH2 and DNMT1 in papillary thyroid carcinoma.
Meng XF; Zhao LY; Chu XF
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2075-2083. PubMed ID: 30915752
[TBL] [Abstract][Full Text] [Related]
15. Twist1 regulates the epithelial-mesenchymal transition via the NF-κB pathway in papillary thyroid carcinoma.
Lv N; Shan Z; Gao Y; Guan H; Fan C; Wang H; Teng W
Endocrine; 2016 Mar; 51(3):469-77. PubMed ID: 26289126
[TBL] [Abstract][Full Text] [Related]
16. Downregulating integrin subunit alpha 7 (ITGA7) promotes proliferation, invasion, and migration of papillary thyroid carcinoma cells through regulating epithelial-to-mesenchymal transition.
Guan Y; Bhandari A; Xia E; Kong L; Zhang X; Wang O
Acta Biochim Biophys Sin (Shanghai); 2020 Feb; 52(2):116-124. PubMed ID: 31942970
[TBL] [Abstract][Full Text] [Related]
17. Activated CXCL5-CXCR2 axis promotes the migration, invasion and EMT of papillary thyroid carcinoma cells via modulation of β-catenin pathway.
Cui D; Zhao Y; Xu J
Biochimie; 2018 May; 148():1-11. PubMed ID: 29471001
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of TRIM26 suppresses the proliferation, metastasis, and glycolysis in papillary thyroid carcinoma cells.
Wang K; Chai L; Qiu Z; Zhang Y; Gao H; Zhang X
J Cell Physiol; 2019 Aug; 234(10):19019-19027. PubMed ID: 30927273
[TBL] [Abstract][Full Text] [Related]
19. DDR2 facilitates papillary thyroid carcinoma epithelial mesenchymal transition by activating ERK2/Snail1 pathway.
Liang Z; Xie WJ; Zhao M; Cheng GP; Wu MJ
Oncol Lett; 2017 Dec; 14(6):8114-8121. PubMed ID: 29250189
[TBL] [Abstract][Full Text] [Related]
20. FKBP51 promotes migration and invasion of papillary thyroid carcinoma through NF-κB-dependent epithelial-to-mesenchymal transition.
Gao Y; Elamin E; Zhou R; Yan H; Liu S; Hu S; Dong J; Wei M; Sun L; Zhao Y
Oncol Lett; 2018 Dec; 16(6):7020-7028. PubMed ID: 30546435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
